Literature DB >> 1260604

Control of lithium tremor with propranolol.

Y D Lapierre.   

Abstract

Lithium tremor is an irregular, nonrhythmic tremor of the distal extremities, variable in both intensity and frequency. It is clinically differentiated from essential tremor and tremors due to anxiety and neuroleptics. The pathophysiologic mechanisms are hypothesized to be of perpheral origin. Five patients were successfully treated with propranolol. In general, the dosage of propranolol must be individually adjusted and is usually from 30 to 40 mg daily in divided doses. This blocker of beta-adrenergic receptors remains effective with long-term administration and increases in dosage are not required.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1260604      PMCID: PMC1956865     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  3 in total

1.  Propranolol and lithium-induced tremor.

Authors:  L Kirk; P C Baastrup; M Schou
Journal:  Lancet       Date:  1972-04-15       Impact factor: 79.321

2.  [Treatment of essential familial tremor with propanolol].

Authors:  A Barbeau
Journal:  Union Med Can       Date:  1973-04

3.  [Clinical treatment of lithium induced tremors with a beta receptor antagonist (propranolol)].

Authors:  L Floru
Journal:  Int Pharmacopsychiatry       Date:  1971
  3 in total
  3 in total

Review 1.  Review of clinically important drug interactions with lithium.

Authors:  N S Harvey; S Merriman
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

2.  Tremor: clinical phenomenology and assessment techniques.

Authors:  Christopher W Hess; Seth L Pullman
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-06-28

3.  Tremor after long term lithium treatment; is it cortical myoclonus?

Authors:  Ptolemaios Georgios Sarrigiannis; Panagiotis Zis; Zoe Charlotte Unwin; Daniel J Blackburn; Nigel Hoggard; Yifan Zhao; Stephen A Billings; Aijaz A Khan; John Yianni; Marios Hadjivassiliou
Journal:  Cerebellum Ataxias       Date:  2019-05-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.